Recognition and management of hypertension in older persons: Focus on African Americans

Journal of the American Geriatrics Society

Volumn 63, Issue 10, 2015, Pages 2130-2138

  Still, Carolyn H ^a,b   Ferdinand, Keith C ^c   Ogedegbe, Gbenga ^d   Wright, Jackson T ^b,e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; clinical trials; hypertension; management of hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR MORTALITY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CONSERVATIVE TREATMENT; DIAGNOSTIC TEST; EARLY INTERVENTION; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; GENETIC SUSCEPTIBILITY; GROUPS BY AGE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MANAGED CARE; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT COMPLIANCE; POPULATION; PRACTICE GUIDELINE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; AGED; BLOOD PRESSURE; CLASSIFICATION; COMPLICATION; COST OF ILLNESS; DISEASE MANAGEMENT; DRUG COMBINATION; DRUG EFFECTS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; KIDNEY DISEASES; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL ISCHEMIA; PREVALENCE; PROCEDURES; PSYCHOLOGY; RISK FACTOR; RISK REDUCTION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; COST OF ILLNESS; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; UNITED STATES;

EID: 84941602045     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13672     Document Type: Article

References (62)

1. Administration on Aging. A Profile of Older Americans, 2011 [on-line]. Available at http://www.aoa.gov/Aging-Statistics/Profile/2012/docs/2012profile.pdf. 2013 Accessed July 16, 2013.
2. James PA, Oparil S, Carter BL, et al., 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
3. Nwankwo T, Yoon SS, Burt V, et al., Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013; 133: 1-8.
4. Heron M,. Deaths: Leading causes for 2010. Natl Vital Stat Rep 2013; 62: 1-96.
5. Mancia G, Fagard R, Narkiewicz K, et al., 2013 ESH/ESC practice guidelines for the management of arterial hypertension. J Hypertens 2013; 31: 1281-1357.
6. Crescioni M, Gorina Y, Bilheimer L, et al., Trends in health status and health care use among older men. Natl Health Stat Report 2010; 24: 1-18.
7. Go A, Mozaffarian D, Roger V, et al., Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014; 129: e28-e292.
8. Liu X, Tsilimingras D, Paul T,. Prevalence and changes of untreated isolated systolic hypertension among non-Hispanic black adults in the United States. Hypertens Res 2014; 37: 685-691.
9. LaVeist T,. Minority Population and Health: Introduction to Health Disparities in the United States. San Francisco: Jossey-Bass, 2005.
10. Nasser SA, Lai Z, O'Connor S, et al., Does earlier attainment of blood pressure goal translate into fewer cardiovascular events? Curr Hypertens Rep 2008; 10: 398-404.
11. Cushman WC, Ford CE, Cutler JA, et al., Success and predictors of blood pressure control in diverse North American settings: The Antihypertensive and Lipid-Lowering Treatment to prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002; 4: 393-404.
12. Lackland DT, Roccella EJ, Deutsch AF, et al., Factors influencing the decline in stroke mortality: A statement from the American Heart Association/American Stroke Association. Stroke 2013; 45: 315-353.
13. Wright JD, Hughes JP, Ostchega Y, et al., Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008. Natl Health Stat Rep 2011; 35: 1-22.
14. Kocemba J, Kawecka-Jaszcz K, Gryglewska B, et al., Isolated systolic hypertension: Pathophysiology, consequences and therapeutic benefits. J Hum Hypertens 1998; 12: 621-626.
15. Aronow WS, Fleg JL, Pepine CJ, et al., ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011; 57: 2037-2114.
16. Duprez DA, Jacobs DR Jr, Lutsey PL, et al., Association of small artery elasticity with incident cardiovascular disease in older adults: The multi-ethnic study of atherosclerosis. Am J Epidemiol 2011; 174: 528-536.
17. Ferdinand KC,. Management of high blood pressure in African Americans and the 2010 ISHIB consensus statement: Meeting an unmet need. J Clin Hypertens (Greenwich) 2010; 12: 237-239.
18. Flack J, Sica DA, Bakris G, et al., Management of high blood pressure in African Americans: An update of the ISHIB Consensus Statement. Hypertension 2010; 56: 780-800.
19. Beckett NS, Peters R, Fletcher AE, et al., Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
20. Chobanian AV, Bakris GL, Black HR, et al., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
21. Langefeld CD, Divers J, Pajewski NM, et al., Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int 2015; 87: 169-175.
22. Fox ER, Young JH, Li Y, et al., Association of genetic variation with systolic and diastolic blood pressure among African Americans: The Candidate Gene Association Resource study. Hum Mol Genet 2011; 20: 2273-2284.
23. Parsa A, Kao WH, Xie D, et al., APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369: 2183-2196.
24. Chobanian AV,. Clinical practice. Isolated systolic hypertension in the elderly. N Engl J Med 2007; 357: 789-796.
25. Duron E, Hanon O,. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008; 4: 363-381.
26. Manolis A, Doumas M,. Sexual dysfunction: The 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens 2008; 26: 2074-2084.
27. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979; 242: 2562-2571.
28. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143-1152.
29. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-3264.
30. Ambrosius WT, Sink KM, Foy CG, et al., The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014; 11: 532-546.
31. Liu L, Zhang Y, Liu G, et al., The Felodipine Event Reduction (FEVER) Study: A randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005; 23: 2157-2172.
32. Verdecchia P, Staessen JA, Angeli F, et al., Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): An open-label randomised trial. Lancet 2009; 374: 525-533.
33. Ogihara T, Saruta T, Rakugi H, et al., Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in elderly isolated systolic hypertension study. Hypertension 2010; 56: 196-202.
34. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31: 2115-2127.
35. Wright JT Jr, Fine LJ, Lackland DT, et al., Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: The minority view. Ann Intern Med 2014; 160: 499-503.
36. Weber MA, Schiffrin EL, White WB, et al., Clinical practice guidelines for the management of hypertension in the community: A statement by the American Society of Hypertension and the International Society of hypertension. J Hypertens 2014; 32: 3-15.
37. Krakoff KR, Gillespie RL, Ferdinand KC, et al., 2014 hypertension recommendations from JNC-8 panel members raise concerns for elderly black and female populations. J Am Coll Cardiol 2014; 64: 394-402.
38. Banach MA, Aronow WS,. Blood pressure J-curve: Current concept. Curr Hypertens Rep 2012; 14: 556-566.
39. Denker MG, Cohen DL,. What is an appropriate blood pressure goal for the elderly: Review of recent studies and practical recommendations. Clin Interv Aging 2013; 8: 1505-1517.
40. Denardo SJ, Gong Y, Nichols WW, et al., Blood pressure and outcomes in very old hypertensive coronary artery disease patients: An INVEST substudy. Am J Med 2010; 123: 719-726.
41. Davis EM, Appel LJ, Wang X, et al., Limitations of analyses based on achieved blood pressure: Lessons from the AASK trial. Hypertension 2011; 57: 1061-1068.
42. Margolis KL, Palermo L, Vittinghoff E, et al., Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: The ACCORD Trial. J Gen Intern Med 2014; 29: 1599-1606.
43. Banach M, Bromfield S, Howard G, et al., Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication. Int J Cardiol 2014; 176: 219-226.
44. The SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. Lancet 2013; 382: 507-515.
45. Parikh SA, Shishehbor MH, Gray BH, et al., SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv 2014; 84: 1163-1171.
46. Odedosu T, Schoenthaler A, Vieira DL, et al., Overcoming barriers to hypertension control in African Americans. Cleve Clin J Med 2012; 79: 46-56.
47. Flack JM, Okwuosa T, Sudhakar R, et al., Should African Americans have a lower blood pressure goal than other ethnic groups to prevent organ damage? Curr Cardiol Rep 2012; 14: 660-666.
48. Go AS, Bauman M, King SM, et al., An effective approach to high blood pressure control: A science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension 2014; 63: 878-885.
49. Appel LJ, Moore TJ, Obarzanek E, et al., A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-1124.
50. Fakhouri TH, Ogden CL, Carroll MD, et al., Prevalence of obesity among older adults in the United States, 2007-2010. NCHS Data Brief 2012; 106: 1-8.
51. Appel LJ, Sacks FM, Carey VJ, et al., Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-2464.
52. Whelton PK, Appel LJ, Espeland MA, et al., Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998; 279: 839-846.
53. Julius S, Alderman MH, Beevers G, et al., Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The LIFE study. J Am Coll Cardiol 2004; 43: 1047-1055.
54. Zanchetti A, Julius S, Kjeldsen S, et al., Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial. J Hypertens 2006; 24: 2163-2168.
55. Wright JT Jr, Probstfield JL, Cushman WC, et al., ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med 2009; 169: 832-842.
56. Jamerson K, Weber MA, Bakris GL, et al., Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428.
57. Chen GJ, Yang MS,. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: A meta-analysis of data from 273,543 participants in 31 randomized controlled trials. PLoS ONE 2013; 8: e57854.
58. Staessen JA, Thijs L, Celis H, et al., Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients-evidence from the Systolic Hypertension in Europe Trial. S Afr Med J 2001; 91: 1060-1068.
59. National Institute for Health and Clinical. Clinical management of primary hypertension in adults. Hypertension 2011 [on-line]. Available at www.nice.org.uk/guidance/CG127 Accessed May 20, 2014.
60. National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis 2012; 60: 850-886.
61. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care 2013; 36 (Suppl 1): S11-S66.
62. Dasgupta K, Quinn R, Zarnke K, et al., The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2014; 30: 485-501.